Jacqueline S. Jeruss, M.D., Ph.D., FACS, was appointed associate dean for regulatory affairs in the Medical School in May 2020.
Dr. Jeruss is an associate professor of surgery, pathology and biomedical engineering. She serves as director of the Breast Cancer Center, the Polly Suk-Yee Cheung Breast Surgical Oncology Fellowship, and the Cancer Genetics and Breast Health Fellowship. She also is co-director of the National Institutes of Health (NIH) Surgical Oncology T32 Training Program, and is a member of the Department of Surgery Executive Committee.
As associate dean, Dr. Jeruss will assist faculty and staff in understanding relevant regulations, institutional policies, and other professionally accepted standards that impact the activities and reputation of the Medical School. Further, she will work with faculty to address concerns in the regulatory realm, mitigate noncompliance risks and resolve noncompliance when it occurs, and bring faculty/staff authorship and research grant disputes to resolution.
Her experiences as a surgeon, scientist, and educator have provided Dr. Jeruss with unique insight into regulatory issues associated with research compliance and the scrutiny of policies linked to laboratory management, federal grant funding, FDA oversight, and protected health information. Additionally, she has a longstanding commitment to medical ethics education, professionalism and conflict resolution, and a broad understanding of issues related to conflict of interest, and both clinical and basic research integrity.
Dr. Jeruss earned her undergraduate degree in neuroscience and history from Brandeis University and her medical degree from the University of Vermont. She completed her general surgery residency training at Northwestern University and holds a Ph.D. from that institution, with her dissertation in the field of breast cancer biology. She completed a fellowship in breast surgical oncology at M.D. Anderson Cancer Center in 2006, and returned to Northwestern, in the Division of Breast Surgery, before joining the University of Michigan faculty in 2014.
Her clinical and basic research program has been supported by the NIH for more than two decades. Her research interests are focused on novel therapeutics for aggressive breast cancer subtypes, new approaches to manage cancer metastasis, incorporation of fertility preservation into the care of young patients with cancer, and surgical ethics. Through her basic science and clinical career, she has served in leadership roles on several national committees, and has been actively involved in the education of students at all levels of training. She also has published numerous manuscripts and book chapters, and received many awards for teaching and research excellence.